Drug prices in the U.S. are significantly higher than those in peer countries, according to new research from RAND. In fact, compared with 32 other countries combined, drug prices in the U.S. are 256% higher.

Imaging advocates praised the policy change, which took effect on Monday, Feb. 1. 

Any physician firm that bills patients directly for their work will have “some level of exposure,” the investor service noted.

The Biden-Harris administration is planning to sign two executive orders to provide healthcare relief for those needing insurance during the COVID-19 pandemic, as well as undo some Trump administration policies that undermined the Affordable Care Act.

A full-service practice might see a 4.24% decrease in the professional component of reimbursement and a 1.78% drop on the global side, according to a new analysis. 

Conservatives, meanwhile, have criticized the selection, citing his history of defending the Affordable Care Act and abortion rights. 

The U.S. Food & Drug Administration first revealed the imaging issue in a recently shared update.

Another quick field check has found the federal rule requiring hospitals to show their prices for shoppable services meeting with only spotty compliance since it went into effect Jan. 1.